LAZARD ASSET MANAGEMENT LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$67,000
-63.0%
449
-63.9%
0.00%
Q2 2022$181,000
+75.7%
1,243
+42.1%
0.00%
Q1 2022$103,000
-14.9%
875
-0.5%
0.00%
Q4 2021$121,000
-90.3%
879
-90.2%
0.00%
-100.0%
Q3 2021$1,249,000
+1369.4%
8,996
+920.0%
0.00%
Q2 2021$85,000
+1114.3%
882
+732.1%
0.00%
Q1 2021$7,000
-86.8%
106
-82.9%
0.00%
Q4 2020$53,0006200.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders